Variant report
Variant | esv3522500 |
---|---|
Chromosome Location | chr3:83891929-83894882 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370666239 | chr3:83891949-83891950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs146530763 | chr3:83891955-83891956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568043634 | chr3:83891973-83891974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187832803 | chr3:83892075-83892076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374050507 | chr3:83892141-83892142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553888459 | chr3:83892200-83892201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35592946 | chr3:83892202-83892203 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs539614193 | chr3:83892242-83892243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557985791 | chr3:83892289-83892290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574955142 | chr3:83892320-83892321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540438823 | chr3:83892328-83892329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576361073 | chr3:83892352-83892353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543689734 | chr3:83892373-83892374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368708869 | chr3:83892397-83892398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573959658 | chr3:83892407-83892408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541103343 | chr3:83892440-83892441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560345483 | chr3:83892442-83892443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190257679 | chr3:83892479-83892480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140957274 | chr3:83892490-83892491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113611810 | chr3:83892576-83892577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs55682559 | chr3:83892597-83892598 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs35189701 | chr3:83892599-83892600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531053171 | chr3:83892603-83892604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75187027 | chr3:83892608-83892609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs5850623 | chr3:83892616-83892617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs397875103 | chr3:83892620-83892621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567899181 | chr3:83892628-83892629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182937327 | chr3:83892649-83892650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535440620 | chr3:83892694-83892695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565731111 | chr3:83892727-83892728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555014540 | chr3:83892737-83892738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541175098 | chr3:83892764-83892765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539546558 | chr3:83892787-83892788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557924181 | chr3:83892807-83892808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576180155 | chr3:83892880-83892881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187575210 | chr3:83892881-83892882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192474933 | chr3:83892892-83892893 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573870545 | chr3:83892916-83892917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540999789 | chr3:83892960-83892961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185017896 | chr3:83892997-83892998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144783894 | chr3:83892998-83892999 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187849565 | chr3:83893013-83893014 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138197836 | chr3:83893034-83893035 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6797807 | chr3:83893044-83893045 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs116296891 | chr3:83893063-83893064 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192482074 | chr3:83893073-83893074 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs28716942 | chr3:83893074-83893075 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs184512328 | chr3:83893120-83893121 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372103594 | chr3:83893133-83893134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73842670 | chr3:83893274-83893275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:83883800-83897800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr3:83892800-83893200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |